Dashboard
Manage Tickers

TXG


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cathie-wood-warns-wall-street-is-missing-ais-biggest-opportunity-in-healthcare-calling-it-sleeper-investment-poised-for-massive-returns
Cathie Wood Warns Wall Street Is Missing A...
10/15/2025 10:17:49

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its p...

my-top-biotech-stock-picks-and-portfolio-strategy-for-the-next-3-10-years
My Top Biotech Stock Picks And Portfolio S...
09/18/2025 17:10:48

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of...

expert-outlook-10x-genomics-through-the-eyes-of-6-analysts
Expert Outlook: 10x Genomics Through The E...
09/11/2025 12:01:59

this-eaton-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This Eaton Analyst Begins Coverage On A Bu...
09/11/2025 11:54:09

piper-sandler-initiates-coverage-on-10x-genomics-with-neutral-rating-announces-price-target-of-15
Piper Sandler Initiates Coverage On 10x Ge...
09/11/2025 11:23:17

Piper Sandler analyst David Westenberg initiates coverage on 10x Genomics (NASDAQ:TXG) with a Neutral rating and announces P...

10x-genomics-and-cliseq-announce-translational-research-collaboration-for-single-cell-applications-in-hematology-clinical-diagnostics
10x Genomics And CLISEQ Announce Translati...
09/09/2025 13:05:45

10x-genomics-launches-xenium-protein
10x Genomics Launches Xenium Protein
08/19/2025 13:13:21

First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deepe...

morgan-stanley-maintains-overweight-on-10x-genomics-lowers-price-target-to-17
Morgan Stanley Maintains Overweight on 10x...
08/12/2025 12:17:05

Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Overweight and lowers the price target from $...

ubs-maintains-neutral-on-10x-genomics-raises-price-target-to-13
UBS Maintains Neutral on 10x Genomics, Rai...
08/08/2025 18:20:50

UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $12 to $13.

analyst-expectations-for-10x-genomicss-future
Analyst Expectations For 10x Genomics's Fu...
08/08/2025 14:01:08

barclays-maintains-overweight-on-10x-genomics-raises-price-target-to-15
Barclays Maintains Overweight on 10x Genom...
08/08/2025 12:47:19

Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $13 to ...

10x-genomics-announces-that-it-has-signed-a-definitive-agreement-to-acquire-scale-biosciences-terms-not-disclosed
10x Genomics Announces That It Has Signed ...
08/07/2025 20:49:15

 10x Genomics, Inc. (NASDAQ:TXG), a leader in single cell and spatial biology, today announced that it has signed a definitive ...

10x-genomics-sees-q3-sales-140000m-144000m-vs-143607m-est
10x Genomics Sees Q3 Sales $140.000M-$144....
08/07/2025 20:15:53

10x Genomics (NASDAQ:TXG) sees Q3 sales of $140.000 million-$144.000 million vs $143.607 million analyst estimate.

10x-genomics-q2-eps-028-beats-036-estimate-sales-172900m-beat-139408m-estimate
10x Genomics Q2 EPS $0.28 Beats $(0.36) Es...
08/07/2025 20:15:13

10x Genomics (NASDAQ:TXG) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $(0.36) b...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

b-of-a-securities-maintains-neutral-on-10x-genomics-raises-price-target-to-13
B of A Securities Maintains Neutral on 10x...
06/26/2025 17:57:43

B of A Securities analyst Derik De Bruin maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from...

demystifying-10x-genomics-insights-from-8-analyst-reviews
Demystifying 10x Genomics: Insights From 8...
06/24/2025 19:00:30

barclays-maintains-overweight-on-10x-genomics-raises-price-target-to-13
Barclays Maintains Overweight on 10x Genom...
06/24/2025 15:08:02

Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $12 to ...

whats-driving-the-market-sentiment-around-10x-genomics
What's Driving the Market Sentiment Around...
06/05/2025 13:00:27

forecasting-the-future-7-analyst-projections-for-10x-genomics
Forecasting The Future: 7 Analyst Projecti...
06/04/2025 18:00:48

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION